• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿硫酸化糖胺聚糖不足与尿路结石中的硫酸软骨素补充。

Urinary sulfated glycosaminoglycan insufficiency and chondroitin sulfate supplement in urolithiasis.

机构信息

STAR Unit of Renal Biochemistry and Stone Disease, Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Department of Chemistry, Faculty of Science, Chulalongkorn University, Bangkok, Thailand.

出版信息

PLoS One. 2019 Mar 7;14(3):e0213180. doi: 10.1371/journal.pone.0213180. eCollection 2019.

DOI:10.1371/journal.pone.0213180
PMID:30845174
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6405089/
Abstract

Familial members of urolithiasis have high risk for stone development. We observed the low sulfated glycosaminoglycan (GAG) excretion in urolithiasis patients and their descendants. In this study, we investigated urinary excretion of sulfated GAG, chondroitin sulfate (CS), heparan sulfate (HS) and hyaluronic acid (HA) in urolithiasis and their children, and explored the effect of CS and HA supplement in urolithic hyperoxaluric rats. The 24-hour urines were collected from urolithiasis patients (28) and their children (40), as well as healthy controls (45) and their children (33) to measure urinary sulfated GAG, CS, HS and HA excretion rate. Our result showed that urinary sulfated GAG and CS were diminished in both urolithiasis patients and their children, while decreased HS and increased HA were observed only in urolithiasis patients. Percentage of HS per sulfated GAG increased in both urolithiasis patients and their children. In hyperoxaluric rats induced by ethylene glycol and vitamin D, we found that CS supplement could prevent stone formation, while HA supplement had no effect on stone formation. Our study revealed that decreased urinary GAG and CS excretion are common in familial members of urolithiasis patients, and CS supplement might be beneficial in calcium oxalate urolithiasis prophylaxis for hyperoxaluric patients.

摘要

结石病患者的家族成员结石发病风险高。我们观察到结石病患者及其后代的硫酸化糖胺聚糖 (GAG) 排泄量较低。在这项研究中,我们研究了结石病患者及其子女的尿硫酸化 GAG、硫酸软骨素 (CS)、硫酸乙酰肝素 (HS) 和透明质酸 (HA) 的排泄情况,并探讨了 CS 和 HA 补充对草酸钙结石高草酸尿症大鼠的影响。收集了 28 名结石病患者和他们的 40 名子女、45 名健康对照者及其 33 名子女的 24 小时尿液,以测量尿硫酸化 GAG、CS、HS 和 HA 的排泄率。我们的结果表明,结石病患者及其子女的尿硫酸化 GAG 和 CS 均减少,而仅在结石病患者中观察到 HS 减少和 HA 增加。硫酸化 GAG 中的 HS 百分比在结石病患者及其子女中均增加。在乙二醇和维生素 D 诱导的高草酸尿症大鼠中,我们发现 CS 补充可预防结石形成,而 HA 补充对结石形成没有影响。我们的研究表明,结石病患者家族成员中普遍存在尿 GAG 和 CS 排泄减少的现象,CS 补充可能有益于高草酸尿症患者的草酸钙结石预防。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b885/6405089/d9984bee9b46/pone.0213180.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b885/6405089/d9984bee9b46/pone.0213180.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b885/6405089/d9984bee9b46/pone.0213180.g001.jpg

相似文献

1
Urinary sulfated glycosaminoglycan insufficiency and chondroitin sulfate supplement in urolithiasis.尿硫酸化糖胺聚糖不足与尿路结石中的硫酸软骨素补充。
PLoS One. 2019 Mar 7;14(3):e0213180. doi: 10.1371/journal.pone.0213180. eCollection 2019.
2
Urinary glycosaminoglycan (uGAG) excretion in healthy pediatric and adolescent population.健康儿童和青少年人群的尿糖胺聚糖(uGAG)排泄情况。
Clin Biochem. 2014 Sep;47(13-14):1341-3. doi: 10.1016/j.clinbiochem.2014.06.012. Epub 2014 Jun 20.
3
Polydispersity of glycosaminoglycans in normal human urine.正常人尿液中糖胺聚糖的多分散性。
Tohoku J Exp Med. 1980 Aug;131(4):327-37. doi: 10.1620/tjem.131.327.
4
Noninvasive diagnosis of tubular damage by the use of the urinary chondroitin-4-sulfate/heparan sulfate ratio.利用尿硫酸软骨素-4/硫酸乙酰肝素比值对肾小管损伤进行无创诊断。
Padiatr Padol. 1986;21(4):357-61.
5
Prospective Evaluation of Chondroitin Sulfate, Heparan Sulfate and Hyaluronic Acid in Prostate Cancer.硫酸软骨素、硫酸乙酰肝素和透明质酸在前列腺癌中的前瞻性评估。
Int Braz J Urol. 2018 Nov-Dec;44(6):1139-1146. doi: 10.1590/S1677-5538.IBJU.2017.0569.
6
Enzymatic determination of urinary glycosaminoglycans from orthopedic patients.酶法测定骨科患者尿糖胺聚糖
Tohoku J Exp Med. 1983 May;140(1):89-96. doi: 10.1620/tjem.140.89.
7
Electrophoretic separation and characterization of urinary glycosaminoglycans and their roles in urolithiasis.尿糖胺聚糖的电泳分离、特性及其在尿路结石形成中的作用
Carbohydr Res. 2007 Jan 15;342(1):79-86. doi: 10.1016/j.carres.2006.11.001. Epub 2006 Nov 7.
8
Plasma and urinary glycosaminoglycans in the course of juvenile idiopathic arthritis.青少年特发性关节炎病程中的血浆和尿糖胺聚糖
Biochem Biophys Res Commun. 2015 Mar 13;458(3):639-643. doi: 10.1016/j.bbrc.2015.02.018. Epub 2015 Feb 13.
9
In vitro studies on the role of glycosaminoglycans in crystallization intensity during infectious urinary stones formation.在感染性尿路结石形成过程中糖胺聚糖对结晶强度作用的体外研究。
APMIS. 2014 Jun;122(6):505-11. doi: 10.1111/apm.12191. Epub 2013 Oct 29.
10
Urinary excretion of glycosaminoglycans in normal and stone forming subjects.
Kidney Int. 1989 Dec;36(6):1022-8. doi: 10.1038/ki.1989.296.

引用本文的文献

1
Advanced Glycation End-Product-Modified Heat Shock Protein 90 May Be Associated with Urinary Stones.晚期糖基化终产物修饰的热休克蛋白90可能与尿路结石有关。
Diseases. 2025 Jan 2;13(1):7. doi: 10.3390/diseases13010007.
2
Sulfated Polysaccharides Reduce the Adhesion of Nano-COM Crystals to Renal Epithelial Cells by Inhibiting Oxidative and Endoplasmic Reticulum Stress.硫酸化多糖通过抑制氧化应激和内质网应激减少纳米磷酸八钙晶体与肾上皮细胞的黏附。
Pharmaceuticals (Basel). 2024 Jun 19;17(6):805. doi: 10.3390/ph17060805.
3
Antioxidant Activity of Polysaccharides with Different Molecular Weights and Cytotoxicity Difference of Polysaccharides Regulated CaOx to HK-2 Cells.

本文引用的文献

1
Urinary stone risk factors in the descendants of patients with kidney stone disease.肾结石病患者后代的尿路结石风险因素。
Pediatr Nephrol. 2018 Jul;33(7):1173-1181. doi: 10.1007/s00467-018-3927-1. Epub 2018 Mar 28.
2
Familial risks in urolithiasis in the population of Sweden.瑞典人群中尿路结石的家族风险
BJU Int. 2018 Mar;121(3):479-485. doi: 10.1111/bju.14096. Epub 2018 Jan 14.
3
Calcium urolithiasis course in young stone formers is influenced by the strength of family history: results from a retrospective study.
不同分子量多糖的抗氧化活性及多糖调节草酸钙对HK-2细胞的细胞毒性差异
Bioinorg Chem Appl. 2023 Dec 23;2023:9968886. doi: 10.1155/2023/9968886. eCollection 2023.
4
Unlocking New Approaches to Urolithiasis Management Nutraceuticals.解锁尿石症管理的新方法:营养保健品。
Curr Pharm Biotechnol. 2024;25(9):1124-1131. doi: 10.2174/1389201024666230821122416.
5
The Alterations and Roles of Glycosaminoglycans in Human Diseases.糖胺聚糖在人类疾病中的改变与作用
Polymers (Basel). 2022 Nov 18;14(22):5014. doi: 10.3390/polym14225014.
6
N-Acetylcysteine and Other Sulfur-Donors as a Preventative and Adjunct Therapy for COVID-19.N-乙酰半胱氨酸及其他硫供体作为COVID-19的预防性和辅助性治疗手段
Adv Pharmacol Pharm Sci. 2022 Aug 10;2022:4555490. doi: 10.1155/2022/4555490. eCollection 2022.
7
Age-Specific Excretion of Calcium, Oxalate, Citrate, and Glycosaminoglycans and Their Ratios in Healthy Children and Children with Urolithiasis.健康儿童和尿路结石儿童尿钙、草酸、枸橼酸和糖胺聚糖及其比值的年龄特异性排泄。
Biomolecules. 2021 May 19;11(5):758. doi: 10.3390/biom11050758.
年轻结石患者的钙结石病程受家族史强度的影响:一项回顾性研究的结果。
Urolithiasis. 2017 Dec;45(6):525-533. doi: 10.1007/s00240-016-0955-9. Epub 2016 Dec 9.
4
Animal models of urinary stone disease.动物模型在尿石病研究中的应用。
Int J Surg. 2016 Dec;36(Pt D):596-606. doi: 10.1016/j.ijsu.2016.11.018. Epub 2016 Nov 10.
5
Calcium oxalate urolithiasis in children: urinary promoters/inhibitors and role of their ratios.儿童草酸钙尿石症:尿液促进剂/抑制剂及其比例的作用
Eur J Pediatr. 2016 Dec;175(12):1959-1965. doi: 10.1007/s00431-016-2792-9. Epub 2016 Oct 11.
6
Family history influences clinical course of idiopathic calcium nephrolithiasis: case-control study of a large cohort of Italian patients.家族史影响特发性钙肾结石的临床病程:对一大群意大利患者的病例对照研究。
J Nephrol. 2016 Oct;29(5):645-51. doi: 10.1007/s40620-015-0225-x. Epub 2015 Aug 22.
7
Urinary glycosaminoglycan (uGAG) excretion in healthy pediatric and adolescent population.健康儿童和青少年人群的尿糖胺聚糖(uGAG)排泄情况。
Clin Biochem. 2014 Sep;47(13-14):1341-3. doi: 10.1016/j.clinbiochem.2014.06.012. Epub 2014 Jun 20.
8
A comparative study of experimental rat models of renal calcium oxalate stone formation.实验性大鼠草酸钙肾结石模型的比较研究。
J Endourol. 2011 Jun;25(6):1057-61. doi: 10.1089/end.2010.0386. Epub 2011 May 13.
9
Familiality of kidney stone disease in Iceland.冰岛肾结石疾病的家族性。
Scand J Urol Nephrol. 2009;43(5):420-4. doi: 10.3109/00365590903151479.
10
Mechanism underlying the low prevalence of pediatric calcium oxalate urolithiasis.小儿草酸钙尿路结石低患病率的潜在机制。
J Urol. 2009 Sep;182(3):1201-9. doi: 10.1016/j.juro.2009.05.007. Epub 2009 Jul 21.